Olbas for Children Inhalation Vapour, Liquid

Země: Irsko

Jazyk: angličtina

Zdroj: HPRA (Health Products Regulatory Authority)

Aktivní složka:

Cajuput oil; Eucalyptus oil; Methyl salicylate; LEVOMENTHOL; Mint oil, partly dementholised

Dostupné s:

GR Lane Health Products Ltd

ATC kód:

R05X

INN (Mezinárodní Name):

Cajuput oil; Eucalyptus oil; Methyl salicylate; LEVOMENTHOL; Mint oil, partly dementholised

Dávkování:

%w/w

Léková forma:

Inhalation vapour, liquid

Druh předpisu:

Product not subject to medical prescription

Terapeutické oblasti:

OTHER COLD PREPARATIONS

Stav Autorizace:

Not marketed

Datum autorizace:

2012-08-03

Charakteristika produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Olbas for Children Inhalation Vapour, Liquid
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Inhalation vapour, liquid.
Colourless to pale yellow transparent liquid.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the relief of bronchial and nasal congestion caused by colds,
catarrh, influenza and hayfever, rhinitis and minor
infections of the respiratory tract.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For inhalation use.
Children aged 3 months to 2 years: Sprinkle 4 drops on to a tissue
placed out of the child’s reach.
Children aged 2 years and over: Sprinkle 8 to 12 drops on to a
handkerchief, or add to hot water and inhale the vapours.
Not recommended for babies under 3 months old.
Do not use for topical application.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Do not allow oil to remain in contact with skin for extended periods.
If symptoms worsen or do not improve after 7 days, contact a doctor.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
No interaction studies have been performed.
Ingredients
% w/w
Cajuput Oil
4.625
Mint Oil, Partly Dementholised
8.863
Eucalyptus Oil
8.863
Levomenthol
1.025
Methyl Salicylate
0.925
For a full list of excipients, see section 6.1.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_0_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_3_
_C_
_R_
_N_
_ _
_2_
_1_
_3_
_6_
_1_
_9_